Andrew Talal, MD

Andrew Talal, MD, is a Professor of Medicine and Founder/Director of the Center for Research and Clinical Care in Liver Disease at the State University of New York at Buffalo - School of Medicine and Biomedical Sciences.

Articles

Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH

Role of Advocacy, Patient Voice in Hepatitis B

Nancy Reau, MD;Andrew Talal, MD;Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the role of advocacy and patient voice in HBV management.

Discussing Unmet Needs in Hepatitis B for 2024

Nancy Reau, MD;Andrew Talal, MD;Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the most pressing unmet needs in HBV for 2024.

Therapeutic Pipeline Updates in Hepatitis B Virus for 2024

Nancy Reau, MD;Andrew Talal, MD;Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on updates in the therapeutic pipeline.

Improving Hepatitis B Screening and Vaccination in 2024

Nancy Reau, MD;Andrew Talal, MD;Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the need to improve HBV screening and vaccination.

Implications of HBV DNA Integration on Care in 2024

Nancy Reau, MD;Andrew Talal, MD;Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on how advancing understanding of HBV DNA integration is influencing care in 2024.

Advances in Pathophysiology of Hepatitis B Virus for 2024

Nancy Reau, MD;Andrew Talal, MD;Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on advances in the pathophysiology of hepatitis b virus for 2024.